Wilmington Savings Fund Society FSB lowered its stake in shares of Target Corporation (NYSE:TGT – Free Report) by 11.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,336 shares of the retailer’s stock after selling 3,008 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Target were worth $2,401,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of TGT. Raleigh Capital Management Inc. raised its stake in Target by 63.4% during the second quarter. Raleigh Capital Management Inc. now owns 263 shares of the retailer’s stock worth $26,000 after purchasing an additional 102 shares during the period. Kozak & Associates Inc. raised its stake in Target by 2,530.0% during the second quarter. Kozak & Associates Inc. now owns 263 shares of the retailer’s stock worth $27,000 after purchasing an additional 253 shares during the period. Investment Research & Advisory Group Inc. purchased a new position in Target during the second quarter worth approximately $29,000. Global Assets Advisory LLC purchased a new position in Target during the second quarter worth approximately $31,000. Finally, WPG Advisers LLC purchased a new position in Target during the first quarter worth approximately $32,000. Hedge funds and other institutional investors own 79.73% of the company’s stock.
Target Stock Performance
TGT stock opened at $90.96 on Thursday. The company has a quick ratio of 0.32, a current ratio of 0.99 and a debt-to-equity ratio of 0.99. The company has a market capitalization of $41.33 billion, a price-to-earnings ratio of 10.60, a P/E/G ratio of 2.59 and a beta of 1.18. Target Corporation has a 12 month low of $85.36 and a 12 month high of $160.79. The firm has a 50 day moving average of $93.67 and a two-hundred day moving average of $96.61.
Target Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Wednesday, November 12th will be paid a $1.14 dividend. The ex-dividend date is Wednesday, November 12th. This is a positive change from Target’s previous quarterly dividend of $1.12. This represents a $4.56 dividend on an annualized basis and a dividend yield of 5.0%. Target’s dividend payout ratio is presently 53.15%.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the stock. Zacks Research raised shares of Target from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Loop Capital set a $95.00 price target on shares of Target in a research report on Thursday, July 17th. Wall Street Zen upgraded shares of Target from a “sell” rating to a “hold” rating in a report on Sunday, August 17th. Barclays reissued an “underweight” rating and issued a $91.00 target price on shares of Target in a research report on Monday, July 21st. Finally, BTIG Research began coverage on shares of Target in a research report on Tuesday. They set a “neutral” rating on the stock. Nine investment analysts have rated the stock with a Buy rating, twenty-five have given a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $109.00.
Read Our Latest Analysis on Target
Target Company Profile
Target Corporation operates as a general merchandise retailer in the United States. The company offers apparel for women, men, boys, girls, toddlers, and infants and newborns, as well as jewelry, accessories, and shoes; and beauty and personal care, baby gear, cleaning, paper products, and pet supplies.
See Also
- Five stocks we like better than Target
- What Are the U.K. Market Holidays? How to Invest and Trade
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How to Use Stock Screeners to Find Stocks
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Profit From Growth Investing
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding TGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Target Corporation (NYSE:TGT – Free Report).
Receive News & Ratings for Target Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target and related companies with MarketBeat.com's FREE daily email newsletter.